Clinical Trial Update: PALONOSETRON X FOSAPREPITANT IN PONV [Phase 4]

View source ↗

Summary

Phase 4 trial update involving palonosetron and fosaprepitant for postoperative nausea and vomiting (PONV).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postoperative Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)
• Palonosetron (palonosetron)

Snippet

Sponsor: Hospital Federal de Bonsucesso | Conditions: Nausea and Vomiting, Postoperative | Phase 4 | Status: UNKNOWN